Investors News

The Investor page website contains information about Opsens Inc. business for stockholders, potential investors, and financial analysts.

Company Profile

Opsens focuses mainly on the measure of FFR in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.

This presentation contains forward-looking statements, reflecting Opsens’ current expectations regarding future events. These statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the successful and timely completion and the commercialization of the products herein. The reader of this document is forewarned concerning the inherent variability and risk associated in terms of strategies or deliverables stated herein by the Company and is cautioned prior to considering these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.